Skip to main content
Fig. 1 | Cell Communication and Signaling

Fig. 1

From: TNFα priming through its interaction with TNFR2 enhances endothelial progenitor cell immunosuppressive effect: new hope for their widespread clinical application

Fig. 1

The impact of TNFα treatment on endothelial markers. CB-ECFCs were treated with different TNFα doses for 24 h and assessed for the percentage of expression and the mean fluorescent intensity of their surface markers. a The expression of CD144 among total CD31+ cells (n = 14), b the expression of VEGFR2 among CD31+CD144+ cells (n = 18), c the expression of TNFR1 among CD31+CD144+ cells (n = 20), d the expression of TNFR2 among CD31+CD144+ cells (n = 20). In representative flow cytometry panels, red histograms depict isotype controls and blue histograms depict the positive expression of desired markers. Data are represented as mean value ± SEM from 4 independent experiments. One way ANOVA analysis was performed to generate P values. ns: non-significant, *P < .05; **P < .01; ***P < .001

Back to article page